MD Analytics conducts surveys with our healthcare professionals panel on topical issues that you may find interesting. We post our results publicly on our website and share them with our panel members in newsletters. Our survey data is visually displayed in an accompanying infographic that you may share with attribution.
Physician specialists are not all alike! MD Analytics surveyed 100 U.S. physician specialists on topics such as work-life balance, patient care, pharma companies, technology, and information sources with the goal of identifying attitudinal differences in order to help pharma marketers more effectively communicate with their target audience. Four segments emerged....
According to our recent research among physician specialists, the younger generation is less engaged with and reliant on pharmaceutical companies than the older generation. When it comes to information sources used in the past six months, online and paper-based medical journal articles are the most common resource for both Younger and Older specialists. However, differences exist in the use of pharmaceutical sales reps (Older 44% vs. Younger 33%) and significantly in the use of pharmaceutical websites (Older 33% vs. Younger 15%). There are also differences in preferred information sources for new products and services, with Older specialists having a stronger...
The World Health Organization (WHO) declared the novel coronavirus (COVID-19) outbreak a global pandemic on March 11, 2020. Now at the three-year mark, the US healthcare workforce is still trying to recover and labor shortages are stressing clinicians and hospitals. MD Analytics surveyed 50 primary care physicians and 109 specialists about the effect of the COVID crisis on staff shortages, as well as their attitudes about support from pharmaceutical companies. In the past year alone, four-fifths of physicians (80% PCPs and 78% Specialists) say they have been impacted by staff shortages, and almost all (98% of PCPs and 87% of...
For many of us, remnants of the pandemic feel like a distant memory. We are back to “normal” – enjoying family gatherings, restaurants and shopping. Even in New York, one of the last COVID-era mandates has come to an end, with masks and face coverings in healthcare facilities no longer required. However, the healthcare system is still dealing with the aftermath, including the impact on physicians. MD Analytics surveyed 50 primary care physicians and 109 specialists about the effect of the COVID crisis on their personal and professional lives. As compared to pre-pandemic, several aspects have gotten worse among physicians....
We are sometimes reminded with stories, movies and books that companies have an origin too. It must have started somehow. Someone must have had a vision or an idea and then worked hard to get it going. MD Analytics is no different in this way and its story follows its own certain path with many team members supporting the company’s growth and quality deliverables throughout the years. At the forefront is the CEO, Tyler Hassman, a fourth generation Canadian, born in Saskatchewan who migrated to British Columbia in the late 90’s; where he held several sales positions during the “dot...
We have all experienced changes in our work since COVID-19 – some of these changes are certainly for the better. Physicians are no different and have experienced significant changes since the start of the pandemic. We surveyed 159 physicians in the U.S. (50 primary care physicians and 109 specialists) to see how things compare to pre-pandemic for them. Workloads initially went down for physicians as patients were hesitant to come into the office and postponed appointments and regular screenings. Both primary physicians and specialists think their workloads are now close to pre-pandemic levels and expected to further increase in the...
Market research is critical at so many stages of product lifecycles as well as one of the tools to evaluate mergers and acquisitions. We know from our own recruiting efforts and experience with our panel providers that response rates to market research invitations tend to be quite low (often under 20%). We surveyed 150 physicians – 50 general practitioners and 90 specialists – to gauge how different factors impact their interest and participation in market research. Interest levels varied by type of study with the highest level of interest for online surveys....
Successful brand launches require engagement and education of the treating physicians. But how do you best engage physicians? We recently surveyed general practitioners (GPs) and specialists to ask them some pertinent questions. Not surprisingly, interest in learning about new products is driven by potential improvements in long-term safety, efficacy, and quality of life. Lower on the list (but still important) are improvements in dosing and administration. Three-quarters of GPs (vs 55% of specialists) want to know about new products once they are approved and/or they have access. This is likely driven by the sheer volume of products and disease areas...
We surveyed 152 physicians in the U.S. to gauge their opinions on Patient Support Program (PSPs) providers during the pandemic. Physicians surveyed include GPs, Hematologists, Medical Oncologists, Rheumatologists, Pulmonologists, Endocrinologists and Infectious Disease Specialists. Overall perceptions of PSPs compared to before the pandemic have generally improved – especially in terms of responsiveness and the expertise of individuals working on PSPs....
PSPs play a significant role in ensuring that patients have the best possible experience during their journey – especially in specialty therapeutic areas where treatments tend to be more expensive. The pandemic has made it more challenging for patients to access support and services for their medical conditions. This has put additional pressure on company-sponsored PSPs to further enhance their offerings to help patients in the best way possible. PSPs have become increasingly important for patients since the onset of the COVID-19 pandemic and as a result now have an even more significant influence on physicians’ treatment selection process. For...
Ready to explore how data-driven insights can accelerate your pharmaceutical research? Connect with our team to discuss your goals.
